Press releases and articles

Impact of SARS-CoV-2 variants on antibody tests

EUROIMMUN Launches SARS-CoV-2 NeutraLISA Assay to Determine the Neutralizing Capacity of Anti-SARS-CoV-2 Antibodies

EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the SARS-CoV-2 NeutraLISA assay, a surrogate neutralization test intended for the detection of neutralizing antibodies against ...

Oncgnostics and EUROIMMUN Announce Collaboration to Distribute Cervical Cancer Test GynTect

EUROIMMUN Launches Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics

EUROIMMUN, a PerkinElmer, Inc. company, today announced the launch of the EUROPattern Microscope Live (EPML) compact immunofluorescence microscope, available with the fourth generation of the ...

EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response

Novel ELISA for Detection of SARS-CoV-2 Antigen in Acutely Infected COVID-19-Patients

New PCR test to differentiate between COVID-19 and flu

EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the CE marked EURORealTime SARS-CoV-2/Influenza A/B for direct detection of SARS-CoV-2, influenza virus type A and influenza virus ...

Novel ELISA for Quantification of Antibodies against S1 Protein of SARS-CoV-2

EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 Protein.
Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and ...

INOCHEM becomes part of EUROIMMUN family

INOCHEM, S.A. DE C.V., a provider of highly specialized tests for accurate diagnostics in clinical laboratories and hospitals in the public and private segments in Mexico, is now part of EUROIMMUN. ...

EURORealTime SARS-CoV-2 approved by the FDA via an Emergency Use Authorization

Subsequent to the EUROIMMUN-Anti-SARS-CoV-2 ELISA (IgG), the EURORealTime SARS-CoV-2 for direct pathogen detection has now also been approved for use in authorised laboratories by the U.S. American ...

Back to top